GBT - Global Blood Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $33.92. This is a potential upside of $33.92 (0%) from yesterday's end of day stock price of $0.

Global Blood Therapeutics's activity chart (see below) currently has 178 price targets and 120 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.22% with an average time for these price targets to be met of 344.72 days.

Most recent stock forecast was given by ANDREW BERENS from LEERINK on 09-Aug-2022. First documented stock forecast 07-Sep-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$68.5

$0.01 (0.01%)

3 years 2 months ago
(09-Aug-2022)

3/4 (75%)

$1.91 (2.87%)

313

Hold

3 years 2 months 1 days ago
(08-Aug-2022)

1/2 (50%)

$28.65 (81.05%)

276

Hold

$67

3 years 2 months 1 days ago
(08-Aug-2022)

7/8 (87.5%)

$36.82 (122.00%)

825

Hold

$133

3 years 2 months 1 days ago
(08-Aug-2022)

1/4 (25%)

$55.56 (71.75%)

567

Hold

$71

3 years 2 months 1 days ago
(08-Aug-2022)

0/1 (0%)

$35.72 (101.25%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GBT (Global Blood Therapeutics) average time for price targets to be met?

On average it took 344.72 days on average for the stock forecasts to be realized with a an average price target met ratio 54.22

Which analyst has the current highest performing score on GBT (Global Blood Therapeutics) with a proven track record?

RITU BARAL

Which analyst has the most public recommendations on GBT (Global Blood Therapeutics)?

Ritu Baral has 21 price targets and 10 ratings on GBT

Which analyst is the currently most bullish on GBT (Global Blood Therapeutics)?

Liana Moussatos with highest potential upside - $83.51

Which analyst is the currently most reserved on GBT (Global Blood Therapeutics)?

Tessa Romero with lowest potential downside - -$32.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?